Camtek Announces Commencement of Public Offering of Ordinary Shares

About this update from Camtek Ltd.

[{"type":"text","content":"MIGDAL HAEMEK, Israel, Nov. 18, 2020 /PRNewswire/ -- Camtek Ltd. (NASDAQ: CAMT) (TASE: CAMT), a leading manufacturer of metrology and inspection equipment, announced today the commencement of a proposed underwritten public offering of three million ordinary shares. Camtek intends to grant the underwriters a 30-day option to purchase up to an additional 15% of its ordinary shares offered in the public offering. All of the shares in the proposed offering are to be sold by Camtek. \nCamtek intends to use the net proceeds from the offering for general corporate purposes, including, but not limited to, potential acquisitions, working capital, capital expenditures, investments, research and development and product development. Camtek has not determined the amount of net proceeds to be used specifically for the foregoing purposes and has no agreements or understandings with respect to any acquisition or investment at this time.\nBarclays and Stifel are acting as the representatives of the underwriters and as joint book-running managers for the proposed offering.\nThe proposed offering is subject to market conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering. \nThe securities described above are being offered by Camtek pursuant to an effective shelf registration statement on Form F-3, including a base prospectus, that was previously filed by Camtek with the Securities and Exchange Commission (the \"SEC\") and that was declared effective on April 21, 2020. This offering will be made only by means of a prospectus supplement and the accompanying prospectus which forms a part of the effective shelf registration statement.\nBefore you invest, you should read the prospectus included in the registration statement, the preliminary prospectus supplement and the other documents Camtek has filed or will file with the SEC for more complete information about Camtek and the proposed offering. You may obtain these documents for free by visiting EDGAR on the SEC's website located at http://www.sec.gov. Alternatively, copies of the preliminary prospectus supplement, when available, and the accompanying base prospectus relating to the proposed offering may be obtained from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Islan...

More updates from Camtek Ltd.